The public health impact of Alzheimer's disease, 2000-2050: potential implication of treatment advances

Annual Review of Public Health
Philip D SloaneS Sudha

Abstract

Recent developments in basic research suggest that therapeutic breakthroughs may occur in Alzheimer's disease treatment over the coming decades. To model the potential magnitude and nature of the effect of these advances, historical data from congestive heart failure and Parkinson's disease were used. Projections indicate that therapies which delay disease onset will markedly reduce overall disease prevalence, whereas therapies to treat existing disease will alter the proportion of cases that are mild as opposed to moderate/severe. The public health impact of such changes would likely involve both the amount and type of health services needed. Particularly likely to arise are new forms of outpatient services, such as disease-specific clinics and centers. None of our models predicts less than a threefold rise in the total number of persons with Alzheimer's disease between 2000 and 2050. Therefore, Alzheimer's care is likely to remain a major public health problem during the coming decades.

References

Jan 1, 1967·Medicina Et Pharmacologia Experimentalis. International Journal of Experimental Medicine·B DjahanguiriA Firouzabadi
Jun 1, 1982·The British Journal of Psychiatry : the Journal of Mental Science·C P HughesR L Martin
Jan 1, 1993·Health Affairs·D P RiceE Segura
Dec 1, 1996·Neurology·W H Poewe, G K Wenning
Mar 1, 1997·Clinical Therapeutics·C J Henke, M J Burchmore
Aug 11, 1998·Nature Genetics·D BlackerR E Tanzi
Nov 21, 1998·Archives of Neurology·B S OkenJ A Kaye
Dec 5, 1998·Science·M Barinaga
Jan 1, 1999·Lancet·W C McCormick, I B Abrass
Mar 25, 1999·The American Journal of Cardiology·J G Cleland, A Clark
Jun 7, 1993·Journal of Health Economics·T Rice
Feb 11, 2000·Neurology·V M MoceriE B Larson
May 5, 2000·The Cochrane Database of Systematic Reviews·D J Feuer, K E Broadley
Oct 18, 2000·The Cochrane Database of Systematic Reviews·J BirksM Tsolaki
Oct 24, 2000·Neurobiology of Disease·P St George-Hyslop
Feb 24, 2001·Journal of Chemical Neuroanatomy·M S FormanJ Q Trojanowski
Mar 20, 2001·Archives of Neurology·R S DoodyJ K Dunn
May 2, 2001·The Cochrane Database of Systematic Reviews·C E Clarke, K H Deane
Jul 11, 2001·The Journals of Gerontology. Series B, Psychological Sciences and Social Sciences·M J MooreE C Clipp
Nov 1, 2001·The Cochrane Database of Systematic Reviews·T LassersonM Greenstone

❮ Previous
Next ❯

Citations

Mar 16, 2011·Archives of Neurology·Robert S WilsonDavid A Bennett
Oct 23, 2002·Journal of Neuroscience Research·Bruce Teter, J Wesson Ashford
Feb 22, 2011·European Journal of Nuclear Medicine and Molecular Imaging·Benjamin A ThomasBrian F Hutton
Sep 3, 2013·International Journal of Health Care Finance and Economics·Rashmita Basu
Aug 21, 2013·Current Neurology and Neuroscience Reports·Giuseppe Tosto, Christiane Reitz
Nov 4, 2009·International Psychogeriatrics·Yunhwan LeeYoun Gu Kim
Apr 9, 2010·International Psychogeriatrics·Adelina Comas-HerreraAlistair Burns
Mar 10, 2012·Journal of the International Neuropsychological Society : JINS·Frederick W UnverzagtSharon L Tennstedt
Nov 19, 2013·Acta Pharmacologica Sinica·Ru-wei JiangJing-kang Shen
Sep 20, 2008·Nature Reviews. Neuroscience·Lars Bertram, Rudolph E Tanzi
Apr 2, 2011·The Journal of Biological Chemistry·Fabiana RenziIban Ubarretxena-Belandia
Aug 13, 2008·The Australian and New Zealand Journal of Psychiatry·Martin TobiasElizabeth Johnson
Jul 25, 2013·Gerontology & Geriatrics Education·Abraham A Brody, James E Galvin
Jan 29, 2011·Aging & Mental Health·Malaz A BoustaniChristopher M Callahan
May 11, 2011·Brain : a Journal of Neurology·James F BurkeKirk A Frey
Oct 19, 2005·The Gerontologist·Sheryl ZimmermanRichard Schulz
Dec 18, 2010·Mutagenesis·Lucia MigliorePhilip Thomas
Mar 10, 2009·Alzheimer Disease and Associated Disorders·Winston W ChungRobert A Stern
May 26, 2010·International Journal of Clinical Practice·D W WrightM Laplaca
Jan 10, 2012·Journal of Family Nursing·Anna Song Beeber, Sheryl Zimmerman
Apr 5, 2013·BMC Public Health·Jae-Hyun ParkHae-Kwan Cheong
Dec 24, 2010·BMC Medicine·Orestes V ForlenzaWagner F Gattaz
Jun 10, 2004·Biological & Pharmaceutical Bulletin·Anthony Lloyd AlbistonSiew Yeen Chai
Sep 28, 2013·PloS One·Wei LiuXiao-Hua Zhou
Nov 26, 2010·Clinical Interventions in Aging·Ahmet Turan Isik
Jun 3, 2010·Clinical Interventions in Aging·Malaz A BoustaniChristopher M Callahan
Dec 1, 2007·Clinical Interventions in Aging·Arthur V EverittDavid G Le Couteur
Jun 1, 2006·Neuropsychiatric Disease and Treatment·Chris FoxCornelius Katona
Jun 30, 2007·Primary Care Companion to the Journal of Clinical Psychiatry·Daniel D Christensen
Sep 2, 2006·Neurological Research·M Cristina PolidoriGereon Nelles

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

Alzheimer's Disease: Tau & TDP-43

Alzheimer's disease is a neurodegenerative disease. This feed focuses on the underlying role of tau proteins and TAR DNA-binding protein 43, as well as other genetic factors, in Alzheimer's disease.

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.

Epidemiology of Aging

This feed focuses on epidemiology of aging and aging-related conditions, including Alzheimer’s disease, dementia, and age-associated cognitive impairment. Here is the latest research.